METTL3 and systemic lupus erythematosus: In conclusion, our study highlights the significance of the m6A-directed posttranscriptional mechanism of METTL3 in CD4+ T-cell activation and differentiation during systemic autoimmune responses, revealing METTL3 as a potential novel target in SLE for therapeutic purposes.